KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Cash from Restructuring (2018 - 2019)

Historic Cash from Restructuring for West Pharmaceutical Services (WST) over the last 2 years, with Q4 2019 value amounting to $700000.0.

  • West Pharmaceutical Services' Cash from Restructuring fell 5000.0% to $700000.0 in Q4 2019 from the same period last year, while for Sep 2020 it was $700000.0, marking a year-over-year decrease of 7666.67%. This contributed to the annual value of $15.3 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q4 2019, West Pharmaceutical Services' Cash from Restructuring is $700000.0, which was down 5000.0% from $1.2 million recorded in Q3 2019.
  • In the past 5 years, West Pharmaceutical Services' Cash from Restructuring registered a high of $1.4 million during Q4 2018, and its lowest value of $100000.0 during Q1 2018.